| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A bibliometric evaluation of the top 100 cited articles on ocrelizumab
|
Altunisik, Erman
|
|
|
77 |
C |
p.
|
artikel
|
| 2 |
A place for biosimilars in the changing multiple sclerosis treatment landscape
|
Greenberg, Benjamin
|
|
|
77 |
C |
p.
|
artikel
|
| 3 |
Assessing the utility of magnetic resonance imaging-based “SuStaIn” disease subtyping for precision medicine in relapsing-remitting and secondary progressive multiple sclerosis
|
Jiang, Xiaotong
|
|
|
77 |
C |
p.
|
artikel
|
| 4 |
Association of chronic periodontitis with multiple sclerosis: A systematic review and meta-analysis
|
Tsimpiris, Athanasios
|
|
|
77 |
C |
p.
|
artikel
|
| 5 |
Beyond the simplicity of theory of mind deficit in multiple sclerosis: from kinetic perception to socio-emotional abstraction and mentalizing
|
Isernia, Sara
|
|
|
77 |
C |
p.
|
artikel
|
| 6 |
Cannabis-based products and multiple sclerosis-related pain: The role of routes of administration
|
Barré, Tangui
|
|
|
77 |
C |
p.
|
artikel
|
| 7 |
Chlamydia pneumonia infection and risk of multiple sclerosis: A meta-analysis
|
Arjmandi, Delaram
|
|
|
77 |
C |
p.
|
artikel
|
| 8 |
Clinical features of MOGAD with brainstem involvement in the initial attack versus NMOSD and MS
|
Xu, Qiao
|
|
|
77 |
C |
p.
|
artikel
|
| 9 |
Clinical risk factors for recurrence of myelin oligodendrocyte glycoprotein antibody-associated disease
|
Wang, Jie
|
|
|
77 |
C |
p.
|
artikel
|
| 10 |
CNS resilience in the progression of MS
|
Giovannoni, Gavin
|
|
|
77 |
C |
p.
|
artikel
|
| 11 |
Cognitive trajectories in relapsing-remitting multiple sclerosis: Evidence of multiple evolutionary trends
|
London, Frédéric
|
|
|
77 |
C |
p.
|
artikel
|
| 12 |
Discrimination of multiple sclerosis using OCT images from two different centers
|
Khodabandeh, Zahra
|
|
|
77 |
C |
p.
|
artikel
|
| 13 |
Effects of disease-modifying therapies on lipid parameters in patients with multiple sclerosis
|
Koca, Nizameddin
|
|
|
77 |
C |
p.
|
artikel
|
| 14 |
Epidemiologic and clinical characteristics of neuromyelitis optica spectrum disorder patients, A seven years follow-up study from Iran
|
Ashtari, Fereshteh
|
|
|
77 |
C |
p.
|
artikel
|
| 15 |
Evaluation of antioxidant parameters of multiple sclerosis patients’ serum according to the disease course
|
Nowak-Kiczmer, Maria
|
|
|
77 |
C |
p.
|
artikel
|
| 16 |
Evaluation of a web-based program for the adoption of wellness behaviors to self-manage fatigue and improve quality of life among people with multiple sclerosis: A randomized waitlist-control trial
|
Titcomb, Tyler J
|
|
|
77 |
C |
p.
|
artikel
|
| 17 |
Fatigue and health-related quality of life depend on the disability status and clinical course in RRMS
|
Ahvenjärvi, Henrik
|
|
|
77 |
C |
p.
|
artikel
|
| 18 |
Impact of adherence to disease modifying therapies on long-term clinical and economic outcomes in multiple sclerosis: A claims analysis of real-world data
|
Amezcua, Lilyana
|
|
|
77 |
C |
p.
|
artikel
|
| 19 |
Impact of interferon beta exposure on birth outcome and child development – Results from the post-authorisation safety study PRIMA
|
Klehmet, Juliane
|
|
|
77 |
C |
p.
|
artikel
|
| 20 |
Incidence of multiple sclerosis relapses and pseudo-relapses following COVID-19 vaccination
|
Labani, Amir
|
|
|
77 |
C |
p.
|
artikel
|
| 21 |
Influence of menstrual cycle and hormonal contraceptive use on MS symptom fluctuations: A pilot study
|
Taylor, Helga
|
|
|
77 |
C |
p.
|
artikel
|
| 22 |
Interferon-beta exposure in-utero and the risk of infections in early childhood
|
Windfeld-Mathiasen, Josefine
|
|
|
77 |
C |
p.
|
artikel
|
| 23 |
Investigation of the safety of live attenuated varicella-zoster virus vaccination in patients with relapse-remitting multiple sclerosis treated with natalizumab: A case series and review of the literature
|
Paybast, Sepideh
|
|
|
77 |
C |
p.
|
artikel
|
| 24 |
Latin American consensus recommendations on the risk of infections in people with multiple sclerosis treated with disease modifying drugs
|
Silva, Berenice A.
|
|
|
77 |
C |
p.
|
artikel
|
| 25 |
Longitudinal epidemiology of multiple sclerosis in Townsville, Queensland, Australia, 2012-2022
|
Simpson-Yap, Steve
|
|
|
77 |
C |
p.
|
artikel
|
| 26 |
MYD88 L265P mutation in neurologic autoimmunity without evidence of malignancy
|
Oetjen, Landon K.
|
|
|
77 |
C |
p.
|
artikel
|
| 27 |
NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis
|
Ammitzbøll, C.
|
|
|
77 |
C |
p.
|
artikel
|
| 28 |
Preliminary race-ethnicity-based analyses of fall risk among people with multiple sclerosis
|
Buehler, Rebekah A.
|
|
|
77 |
C |
p.
|
artikel
|
| 29 |
Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey
|
Altieri, Manuela
|
|
|
77 |
C |
p.
|
artikel
|
| 30 |
Radiological abnormalities in progressive multifocal leukoencephalopathy: Identifying typical and atypical imaging patterns for early diagnosis and differential considerations
|
Soni, Neetu
|
|
|
77 |
C |
p.
|
artikel
|
| 31 |
Relationship of tryptophan metabolites with the type and severity of multiple sclerosis
|
Isık, Saziye Melike Turan
|
|
|
77 |
C |
p.
|
artikel
|
| 32 |
Role of serostatus in pediatric neuromyelitis optica spectrum disorders: A nationwide multicentric study
|
Solmaz, Ismail
|
|
|
77 |
C |
p.
|
artikel
|
| 33 |
Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: A phase 2b, randomized, double-blind, placebo-controlled trial by Daniel S Reich et Al.
|
Zurmati, Bakht Muhammad
|
|
|
77 |
C |
p.
|
artikel
|
| 34 |
Serum Neurofilaments are a reliable biomarker to early detect PML in Multiple Sclerosis patients
|
Valentino, P
|
|
|
77 |
C |
p.
|
artikel
|
| 35 |
Social relations and leisure activities as predictors of wellbeing among older adults with multiple sclerosis: A cross-sectional survey study in Denmark
|
Bergien, Sofie Olsgaard
|
|
|
77 |
C |
p.
|
artikel
|
| 36 |
Thalamic asymmetry in Multiple Sclerosis
|
Ramezani, Neda
|
|
|
77 |
C |
p.
|
artikel
|
| 37 |
The biological sample collection of the OFSEP French MS registry: An essential tool dedicated to researchers
|
Brocard, Guillaume
|
|
|
77 |
C |
p.
|
artikel
|
| 38 |
The NHANES Biological Age Index demonstrates accelerated aging in MS patients
|
Miner, Annalise E.
|
|
|
77 |
C |
p.
|
artikel
|
| 39 |
The nutritional risk in patients with neuromyelitis optica spectrum disorder
|
Huang, Rui
|
|
|
77 |
C |
p.
|
artikel
|
| 40 |
The rate of force relaxation scaling factor is highly sensitive to detect upper and lower extremity motor deficiencies in mildly affected people with multiple sclerosis
|
Uygur, Mehmet
|
|
|
77 |
C |
p.
|
artikel
|
| 41 |
The relation of sarcopenia and disability in multiple sclerosis
|
Haider, Lukas
|
|
|
77 |
C |
p.
|
artikel
|
| 42 |
Towards a more precise rating of neurological disability in multiple sclerosis: A new automatic and linear quantification of limbs function
|
Cohen, Mikael
|
|
|
77 |
C |
p.
|
artikel
|
| 43 |
Trans-synaptic degeneration in the optic pathway: Exploring the role of lateral geniculate nucleus in early stages of relapsing-remitting multiple sclerosis
|
Miante, Silvia
|
|
|
77 |
C |
p.
|
artikel
|
| 44 |
Use of follow-on fingolimod for multiple sclerosis: Analysis of effectiveness and patient reported outcomes in a real-world clinical setting
|
Altunan, Bengü
|
|
|
77 |
C |
p.
|
artikel
|
Tijdschrift beschrijving